Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of increased bowel motility with Senokot on predialysis serum potassium in maintenance hemodialysis patients
TCTR20210303001Phase 2Completed
- Sponsor
- N/A
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sennosides in end-stage kidney disease (ESKD), hyperkalemia, sponsored by N/A. Started Aug 2019; status: completed.
02
Drugs
sennosides
03
Conditions
end-stage kidney disease (ESKD)hyperkalemia
Beyond the preview
Go deeper on TCTR20210303001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210303001.